The abnormal expression of histone deacetylase (HDAC) in normal tissues and cells will promote the development of a tumor, and it is related to the proliferation and apoptosis, angiogenesis, metastasis, and drug resistance of tumor cells, and becomes a new target of tumor treatment [206–209]. The gene discussed is HDAC9; the disease is neoplasm.